| pubmed-article:15993857 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15993857 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:15993857 | lifeskim:mentions | umls-concept:C0028768 | lld:lifeskim |
| pubmed-article:15993857 | lifeskim:mentions | umls-concept:C0073379 | lld:lifeskim |
| pubmed-article:15993857 | lifeskim:mentions | umls-concept:C1293122 | lld:lifeskim |
| pubmed-article:15993857 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:15993857 | pubmed:dateCreated | 2005-9-5 | lld:pubmed |
| pubmed-article:15993857 | pubmed:abstractText | Most patients with obsessive-compulsive disorder (OCD) show only partial reduction of symptoms with standard therapy. Recent imaging data suggests glutamatergic dysfunction in the corticostriatal pathway in OCD. We investigated the efficacy of augmentation therapy with riluzole, a glutamate-modulating agent, in treatment-resistant OCD. | lld:pubmed |
| pubmed-article:15993857 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15993857 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15993857 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15993857 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15993857 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15993857 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15993857 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15993857 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15993857 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:15993857 | pubmed:issn | 0006-3223 | lld:pubmed |
| pubmed-article:15993857 | pubmed:author | pubmed-author:MalisonRobert... | lld:pubmed |
| pubmed-article:15993857 | pubmed:author | pubmed-author:MathalonDanie... | lld:pubmed |
| pubmed-article:15993857 | pubmed:author | pubmed-author:KrystalJohn... | lld:pubmed |
| pubmed-article:15993857 | pubmed:author | pubmed-author:WuYu-TeYT | lld:pubmed |
| pubmed-article:15993857 | pubmed:author | pubmed-author:SanacoraGerar... | lld:pubmed |
| pubmed-article:15993857 | pubmed:author | pubmed-author:PittengerChri... | lld:pubmed |
| pubmed-article:15993857 | pubmed:author | pubmed-author:GueorguievaRa... | lld:pubmed |
| pubmed-article:15993857 | pubmed:author | pubmed-author:CoricVladimir... | lld:pubmed |
| pubmed-article:15993857 | pubmed:author | pubmed-author:WasylinkSuzan... | lld:pubmed |
| pubmed-article:15993857 | pubmed:author | pubmed-author:TaskiranSarpe... | lld:pubmed |
| pubmed-article:15993857 | pubmed:author | pubmed-author:ValentineGera... | lld:pubmed |
| pubmed-article:15993857 | pubmed:author | pubmed-author:SaksaJohnJ | lld:pubmed |
| pubmed-article:15993857 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15993857 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:15993857 | pubmed:volume | 58 | lld:pubmed |
| pubmed-article:15993857 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15993857 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15993857 | pubmed:pagination | 424-8 | lld:pubmed |
| pubmed-article:15993857 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:15993857 | pubmed:meshHeading | pubmed-meshheading:15993857... | lld:pubmed |
| pubmed-article:15993857 | pubmed:meshHeading | pubmed-meshheading:15993857... | lld:pubmed |
| pubmed-article:15993857 | pubmed:meshHeading | pubmed-meshheading:15993857... | lld:pubmed |
| pubmed-article:15993857 | pubmed:meshHeading | pubmed-meshheading:15993857... | lld:pubmed |
| pubmed-article:15993857 | pubmed:meshHeading | pubmed-meshheading:15993857... | lld:pubmed |
| pubmed-article:15993857 | pubmed:meshHeading | pubmed-meshheading:15993857... | lld:pubmed |
| pubmed-article:15993857 | pubmed:meshHeading | pubmed-meshheading:15993857... | lld:pubmed |
| pubmed-article:15993857 | pubmed:meshHeading | pubmed-meshheading:15993857... | lld:pubmed |
| pubmed-article:15993857 | pubmed:meshHeading | pubmed-meshheading:15993857... | lld:pubmed |
| pubmed-article:15993857 | pubmed:meshHeading | pubmed-meshheading:15993857... | lld:pubmed |
| pubmed-article:15993857 | pubmed:meshHeading | pubmed-meshheading:15993857... | lld:pubmed |
| pubmed-article:15993857 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15993857 | pubmed:articleTitle | Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial. | lld:pubmed |
| pubmed-article:15993857 | pubmed:affiliation | Department of Psychiatry, Yale University School of Medicine and Connecticut Mental Health Center, 34 Park Street, New Haven, CT 06519, USA. vladimir.coric@yale.edu | lld:pubmed |
| pubmed-article:15993857 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15993857 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:15993857 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:15993857 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:15993857 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
| pubmed-article:15993857 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:15993857 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15993857 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15993857 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15993857 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15993857 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15993857 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15993857 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15993857 | lld:pubmed |
